Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Once Daily vs PRN PDE5 Inhibitors in ED
NCT00734604Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of tadalafil in erectile dysfunction (ED), sponsored by Eli Lilly and Company. Started Aug 2008; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00734604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734604.